Differential regulation of the expressions of the PGC-1α splice variants, lipins, and PPARα in heart compared to liver

Journal of Lipid Research

Volumn 54, Issue 6, 2013, Pages 1662-1677

  Kok, Bernard P C ^a   Dyck, Jason R B ^a   Harris, Thurl E ^b   Brindley, David N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Fasting; Glycerolipid; Hepatic and cardiac gene regulation; Phosphatidate phosphatase

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1B; CELL PROTEIN; CYCLIC AMP; GLUCOCORTICOID; GLYCEROLIPID; LIPIN; LIPIN 1; LIPIN 2; LIPIN 3; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; GENE EXPRESSION; HEART; HEART MUSCLE CELL; LIPOGENESIS; LIVER; LIVER CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

FASTING; GLYCEROLIPID; HEPATIC AND CARDIAC GENE REGULATION; PHOSPHATIDATE PHOSPHATASE;

ALTERNATIVE SPLICING; ANIMALS; FASTING; FATTY ACIDS; GENE EXPRESSION REGULATION; LIVER; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; ORGANIC CHEMICALS; OXIDATION-REDUCTION; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTORS;

EID: 84877895229     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M036624     Document Type: Article

References (59)

1. Leone, T. C., C. J. Weinheimer, and D. P. Kelly. 1999. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA. 96: 7473-7478. (Pubitemid 29299686)
2. Finck, B. N., J. J. Lehman, T. C. Leone, M. J. Welch, M. J. Bennett, A. Kovacs, X. Han, R. W. Gross, R. Kozak, G. D. Lopaschuk, et al. 2002. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109: 121-130. (Pubitemid 34052548)
3. Kersten, S., J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, and W. Wahli. 1999. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103: 1489-1498.
4. Gilde, A. J., K. A. van der Lee, P. H. Willemsen, G. Chinetti, F. R. van der Leij, G. J. van der Vusse, B. Staels, and M. van Bilsen. 2003. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ. Res. 92: 518-524. (Pubitemid 36368664)
5. Campbell, F. M., R. Kozak, A. Wagner, J. Y. Altarejos, J. R. Dyck, D. D. Belke, D. L. Severson, D. P. Kelly, and G. D. Lopaschuk. 2002. A role for peroxisome proliferator-activated receptor alpha (PPARalpha) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase. J. Biol. Chem. 277: 4098-4103. (Pubitemid 34968667)
6. Finck, B. N., M. C. Gropler, Z. Chen, T. C. Leone, M. A. Croce, T. E. Harris, J. C. Lawrence, Jr., and D. P. Kelly. 2006. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab. 4: 199-210. (Pubitemid 44283957)
7. Finck, B. N., and D. P. Kelly. 2006. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116: 615-622. (Pubitemid 43326866)
8. Herzig, S., F. Long, U. S. Jhala, S. Hedrick, R. Quinn, A. Bauer, D. Rudolph, G. Schutz, C. Yoon, P. Puigserver, et al. 2001. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature. 413: 179-183. (Pubitemid 32867880)
9. Yoon, J. C., P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C. R. Kahn, D. K. Granner, et al. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 413: 131-138. (Pubitemid 32867868)
10. Miura, S., Y. Kai, Y. Kamei, and O. Ezaki. 2008. Isoform-specific increases in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to beta2-adrenergic receptor activation and exercise. Endocrinology. 149: 4527-4533.
11. Reue, K., and D. N. Brindley. 2008. Thematic Review Series: Glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism. J. Lipid Res. 49: 2493-2503.
12. Harris, T. E., and B. N. Finck. 2011. Dual function lipin proteins and glycerolipid metabolism. Trends Endocrinol. Metab. 22: 226-233.
13. Kok, B. P., G. Venkatraman, D. Capatos, and D. N. Brindley. 2012. Unlike two peas in a pod: lipid phosphate phosphatases and phosphatidate phosphatases. Chem. Rev. 112: 5121-5146.
14. Donkor, J., P. Zhang, S. Wong, L. O'Loughlin, J. Dewald, B. P. Kok, D. N. Brindley, and K. Reue. 2009. A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2. J. Biol. Chem. 284: 29968-29978.
15. Donkor, J., M. Sariahmetoglu, J. Dewald, D. N. Brindley, and K. Reue. 2007. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J. Biol. Chem. 282: 3450-3457. (Pubitemid 47084457)
16. Han, G. S., and G. M. Carman. 2010. Characterization of the human LPIN1-encoded phosphatidate phosphatase isoforms. J. Biol. Chem. 285: 14628-14638.
17. Gropler, M. C., T. E. Harris, A. M. Hall, N. E. Wolins, R. W. Gross, X. Han, Z. Chen, and B. N. Finck. 2009. Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice. J. Biol. Chem. 284: 6763-6772.
18. Bou Khalil, M., M. Sundaram, H. Y. Zhang, P. H. Links, J. F. Raven, B. Manmontri, M. Sariahmetoglu, K. Tran, K. Reue, D. N. Brindley, et al. 2009. The level and compartmentalization of phosphatidate phosphatase-1 (lipin-1) control the assembly and secretion of hepatic VLDL. J. Lipid Res. 50: 47-58.
19. 2+-dependent phosphatidate phosphatase enzyme. J. Biol. Chem. 281: 9210-9218.
20. Burroughs, A. M., K. N. Allen, D. Dunaway-Mariano, and L. Aravind. 2006. Evolutionary genomics of the HAD superfamily: understanding the structural adaptations and catalytic diversity in a superfamily of phosphoesterases and allied enzymes. J. Mol. Biol. 361: 1003-1034. (Pubitemid 44192587)
21. Carman, G. M., and G. S. Han. 2006. Roles of phosphatidate phosphatase enzymes in lipid metabolism. Trends Biochem. Sci. 31: 694-699. (Pubitemid 44791946)
22. Hopewell, R., P. Martin-Sanz, A. Martin, J. Saxton, and D. N. Brindley. 1985. Regulation of the translocation of phosphatidate phosphohydrolase between the cytosol and the endoplasmic reticulum of rat liver. Effects of unsaturated fatty acids, spermine, nucleotides, albumin and chlorpromazine. Biochem. J. 232: 485-491. (Pubitemid 16210782)
23. Cascales, C., E. H. Mangiapane, and D. N. Brindley. 1984. Oleic acid promotes the activation and translocation of phosphatidate phosphohydrolase from the cytosol to particulate fractions of isolated rat hepatocytes. Biochem. J. 219: 911-916. (Pubitemid 14141749)
24. Harris, T. E., T. A. Huffman, A. Chi, J. Shabanowitz, D. F. Hunt, A. Kumar, and J. C. Lawrence, Jr. 2007. Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1. J. Biol. Chem. 282: 277-286. (Pubitemid 47076630)
25. Karanasios, E., G. S. Han, Z. Xu, G. M. Carman, and S. Siniossoglou. 2010. A phosphorylation-regulated amphipathic helix controls the membrane translocation and function of the yeast phosphatidate phosphatase. Proc. Natl. Acad. Sci. USA. 107: 17539-17544.
26. Manmontri, B., M. Sariahmetoglu, J. Donkor, M. B. Khalil, M. Sundaram, Z. Yao, K. Reue, R. Lehner, and D. N. Brindley. 2008. Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically. J. Lipid Res. 49: 1056-1067.
27. Mitra, M. S., J. D. Schilling, X. Wang, P. Y. Jay, J. M. Huss, X. Su, and B. N. Finck. 2011. Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor gamma coactivator 1alpha/estrogen related receptor axis. J. Mol. Cell. Cardiol. 51: 120-128.
28. Zhang, P., L. O'Loughlin, D. N. Brindley, and K. Reue. 2008. Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis. J. Lipid Res. 49: 1519-1528.
29. Pittner, R. A., R. Fears, and D. N. Brindley. 1985. Effects of cyclic AMP, glucocorticoids and insulin on the activities of phosphatidate phosphohydrolase, tyrosine aminotransferase and glycerol kinase in isolated rat hepatocytes in relation to the control of triacylglycerol synthesis and gluconeogenesis. Biochem. J. 225: 455-462. (Pubitemid 15162191)
30. Lopaschuk, G. D., J. R. Ussher, C. D. Folmes, J. S. Jaswal, and W. C. Stanley. 2010. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90: 207-258.
31. Saddik, M., and G. D. Lopaschuk. 1991. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J. Biol. Chem. 266: 8162-8170. (Pubitemid 21906491)
32. Haemmerle, G., T. Moustafa, G. Woelkart, S. Buttner, A. Schmidt, T. van de Weijer, M. Hesselink, D. Jaeger, P. C. Kienesberger, K. Zierler, et al. 2011. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1. Nat. Med. 17: 1076-1085.
33. Kienesberger, P. C., T. Pulinilkunnil, J. Nagendran, and J. R. Dyck. 2013. Myocardial triacylglycerol metabolism. J. Mol. Cell. Cardiol. 55: 101-110.
34. Giannopoulos, G., Z. Hassan, and S. Solomon. 1974. Glucocorticoid receptors in fetal and adult rabbit tissues. J. Biol. Chem. 249: 2424-2427.
35. Pujols, L., J. Mullol, J. Roca-Ferrer, A. Torrego, A. Xaubet, J. A. Cidlowski, and C. Picado. 2002. Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. Am. J. Physiol. Cell Physiol. 283: C1324-C1331.
36. Kovacic, S., C. L. Soltys, A. J. Barr, I. Shiojima, K. Walsh, and J. R. Dyck. 2003. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J. Biol. Chem. 278: 39422-39427. (Pubitemid 37248497)
37. Kok, B. P., P. C. Kienesberger, J. R. Dyck, and D. N. Brindley. 2012. Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) mice. J. Lipid Res. 53: 105-118.
38. Martin, A., A. Gómez-Muñoz, Z. Jamal, and D. N. Brindley. 1991. Characterization and assay of phosphatidate phosphatase. Methods Enzymol. 197: 553-563.
39. Ko, K. W., B. Erickson, and R. Lehner. 2009. Es-x/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes. Biochim. Biophys. Acta. 1791: 1133-1143.
40. Mangiapane, E. H., and D. N. Brindley. 1986. Effects of dexamethasone and insulin on the synthesis of triacylglycerols and phosphatidylcholine and the secretion of very-low-density lipoproteins and lysophosphatidylcholine by monolayer cultures of rat hepatocytes. Biochem. J. 233: 151-160. (Pubitemid 16063785)
41. Martin, A., P. A. Duffy, C. Liossis, A. Gómez-Muñoz, L. O'Brien, J. C. Stone, and D. N. Brindley. 1997. Increased concentrations of phosphatidate, diacylglycerol and ceramide in ras- and tyrosine kinase (fps)-transformed fibroblasts. Oncogene. 14: 1571-1580. (Pubitemid 27182840)
42. Mackall, J., M. Meredith, and M. D. Lane. 1979. A mild procedure for the rapid release of cytoplasmic enzymes from cultured animal cells. Anal. Biochem. 95: 270-274. (Pubitemid 9194292)
43. Saggerson, E. D., and A. L. Greenbaum. 1969. The effect of dietary and hormonal conditions on the activities of glycolytic enzymes in rat epididymal adipose tissue. Biochem. J. 115: 405-417.
44. Xu, H. E., T. B. Stanley, V. G. Montana, M. H. Lambert, B. G. Shearer, J. E. Cobb, D. D. McKee, C. M. Galardi, K. D. Plunket, R. T. Nolte, et al. 2002. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature. 415: 813-817. (Pubitemid 34150506)
45. Pearen, M. A., S. A. Myers, S. Raichur, J. G. Ryall, G. S. Lynch, and G. E. Muscat. 2008. The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. Endocrinology. 149: 2853-2865. (Pubitemid 351724495)
46. Xiao, R. P. 2001. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Sci. STKE. 104: re15.
47. Xiao, R. P., W. Zhu, M. Zheng, C. Cao, Y. Zhang, E. G. Lakatta, and Q. Han. 2006. Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends Pharmacol. Sci. 27: 330-337. (Pubitemid 43850004)
48. Vavrečka, M., M. P. Mitchell, and G. Hübscher. 1969. The effect of starvation on the incorporation of palmitate into glycerides and phospholipids of rat liver homogenates. Biochem. J. 115: 139-145.
49. Peterson, T. R., S. S. Sengupta, T. E. Harris, A. E. Carmack, S. A. Kang, E. Balderas, D. A. Guertin, K. L. Madden, A. E. Carpenter, B. N. Finck, et al. 2011. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell. 146: 408-420.
50. Schoonderwoerd, K., S. Broekhoven-Schokker, W. C. Hülsmann, and H. Stam. 1990. Properties of phosphatidate phosphohydrolase and diacylglycerol acyltransferase activities in the isolated rat heart. Effect of glucagon, ischaemia and diabetes. Biochem. J. 268: 487-492. (Pubitemid 20193993)
51. Jamal, Z., A. Martin, A. Gómez-Muñoz, P. Hales, E. Chang, J. C. Russell, and D. N. Brindley. 1992. Phosphatidate phosphohydrolases in liver, heart and adipose tissue of the JCR:LA corpulent rat and the lean genotypes: implications for glycerolipid synthesis and signal transduction. Int. J. Obes. Relat. Metab. Disord. 16: 789-799.
52. Burgdorf, C., L. Hansel, M. Heidbreder, O. Johren, F. Schutte, H. Schunkert, and T. Kurz. 2009. Suppression of cardiac phosphatidate phosphohydrolase 1 activity and lipin mRNA expression in Zucker diabetic fatty rats and humans with type 2 diabetes mellitus. Biochem. Biophys. Res. Commun. 390: 165-170.
53. Ryu, D., K. J. Oh, H. Y. Jo, S. Hedrick, Y. N. Kim, Y. J. Hwang, T. S. Park, J. S. Han, C. S. Choi, M. Montminy, et al. 2009. TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1. Cell Metab. 9: 240-251.
54. Dwyer, J. R., J. Donkor, P. Zhang, L. S. Csaki, L. Vergnes, J. M. Lee, J. Dewald, D. N. Brindley, E. Atti, S. Tetradis, et al. 2012. Mouse lipin-1 and lipin-2 cooperate to maintain glycerolipid homeostasis in liver and aging cerebellum. Proc. Natl. Acad. Sci. USA. 109: E2486-E2495.
55. Escher, P., O. Braissant, S. Basu-Modak, L. Michalik, W. Wahli, and B. Desvergne. 2001. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology. 142: 4195-4202. (Pubitemid 32907045)
56. Van der Lee, K. A., P. H. Willemsen, S. Samec, J. Seydoux, A. G. Dulloo, M. M. Pelsers, J. F. Glatz, G. J. Van der Vusse, and M. Van Bilsen. 2001. Fasting-induced changes in the expression of genes controlling substrate metabolism in the rat heart. J. Lipid Res. 42: 1752-1758. (Pubitemid 33116706)
57. Mascaro, C., E. Acosta, J. A. Ortiz, P. F. Marrero, F. G. Hegardt, and D. Haro. 1998. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J. Biol. Chem. 273: 8560-8563. (Pubitemid 28176129)
58. Brandt, J. M., F. Djouadi, and D. P. Kelly. 1998. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 273: 23786-23792. (Pubitemid 28435712)
59. Brady, P. S., and L. J. Brady. 1989. Regulation of carnitine palmitoyltransferase in vivo by glucagon and insulin. Biochem. J. 258: 677-682. (Pubitemid 19083525)